MoneyWorks4Me

Medicamen Biotech informs about disclosure

30 Dec 2020 Evaluate
Medicamen Biotech has informed that it has enclosed the disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received from Shivalik Rasayan & Growel Remedies for purchase and sale of equity shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..